Technology Insight: Detecting growth hormone abuse in athletes

Nature Clinical Practice Endocrinology and Metabolism

Volumn 3, Issue 11, 2007, Pages 769-777

  Bidlingmaier, Martin ^a   Strasburger, Christian J ^b  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Doping; Growth hormone; Isoforms; Pharmacodynamic end points; Sport

Indexed keywords

GROWTH HORMONE; RECOMBINANT GROWTH HORMONE;

ATHLETE; BONE TURNOVER; DOPING; GROWTH RETARDATION; HORMONE ACTION; HUMAN; HYPOPHYSIS FUNCTION; IMMUNOASSAY; PRIORITY JOURNAL; REVIEW; SHORT STATURE; SOFT TISSUE;

BIOLOGICAL MARKERS; DOPING IN SPORTS; HUMAN GROWTH HORMONE; HUMANS; IMMUNOASSAY; PROTEIN ISOFORMS; RECOMBINANT PROTEINS;

EID: 35448993338     PISSN: 17458366     EISSN: 17458374     Source Type: Journal    
DOI: 10.1038/ncpendmet0644     Document Type: Review

References (71)

1. Duchaine D (1983) Underground Steroid Handbook. Venice, CA: HLR Technical Books
2. Berggren A et al. (2005) Short-term administration of supraphysiological recombinant human growth hormone (GH) does not increase maximum endurance exercise capacity in healthy, active young men and women with normal GH-insulin-like growth factor I axes. J Clin Endocrinol Metab 90: 3268-3273
3. Rennie MJ (2003) Claims for the anabolic effects of growth hormone: a case of the emperor's new clothes? Br J Sports Med 37: 100-105
4. Ehrnborg C et al. (2005) Supraphysiological growth hormone: less fat, more extracellular fluid but uncertain effects on muscles in healthy, active young adults. Clin Endocrinol (Oxf) 62: 449-457
5. Rickert VI et al. (1992) Human growth hormone: a new substance of abuse among adolescents? Clin Pediatr (Phila) 31: 723-726
6. Wanjek B et al. (2007) Doping, drugs and drug abuse among adolescents in the state of Thuringia (Germany): prevalence, knowledge and attitudes. Int J Sports Med 28: 346-353
7. World Anti-Doping Agency: Prohibited List [www.wada-ama.org/en/ prohibitedlist.ch2] (accessed 18 July 2007)
8. Abramson FP et al. (1996) Isotopic differences in human growth hormone preparations. Anal Chem 68: 1971-1972
9. Andersson C et al. (1996) Isolation and characterization of a trisulfide variant of recombinant human growth hormone formed during expression in Escherichia coli. Int J Pept Protein Res 47: 311-321
10. Hepner F et al. (2006) Mass spectrometrical analysis of recombinant human growth hormone norditropin reveals amino acid exchange at M14_V14 rhGH. Proteomics 6: 775-784
11. Lasne F and de Ceaurriz J (2000) Recombinant erythropoietin in urine. Nature 405: 635
12. De Frutos M et al. (2003) Differences in capillary electrophoresis profiles of urinary and recombinant erythropoietin. Electrophoresis 24: 678-680
13. Lasne F et al. (2002) Detection of isoelectric profiles of erythropoietin in urine: differentiation of natural and administered recombinant hormones. Anal Biochem 311: 119-126
14. Sasaki H et al. (1987) Carbohydrate structure of erythropoietin expressed in Chinese hamster ovary cells by a human erythropoietin cDNA. J Biol Chem 262: 12059-12076
15. Rice KG et al. (1992) Quantitative mapping of the N-linked sialyloligosaccharides of recombinant erythropoietin: combination of direct high-performance anion-exchange chromatography and 2-aminopyridine derivatization. Anal Biochem 206: 278-287
16. Lasne F (2003) Double-blotting: a solution to the problem of nonspecific binding of secondary antibodies in immunoblotting procedures. J Immunol Methods 276: 223-226
17. Van Cauter E et al. (1992) A quantitative estimation of growth hormone secretion in normal man: reproducibility and relation to sleep and time of day. J Clin Endocrinol Metab 74: 1441-1450
18. Hartman ML et al. (1991) Temporal structure of in vivo growth hormone secretory events in humans. Am J Physiol 260: E101-E110
19. Kanaley JA et al. (1999) Obesity attenuates the growth hormone response to exercise. J Clin Endocrinol Metab 84: 3156-3161
20. Richter SD et al. (1996) Time kinetics of the endocrine response to acute psychological stress. J Clin Endocrinol Metab 81: 1956-1960
21. Pritzlaff CJ et al. (1999) Impact of acute exercise intensity on pulsatile growth hormone release in men. J Appl Physiol 87: 498-504
22. Wideman L et al. (2002) Growth hormone release during acute and chronic aerobic and resistance exercise: recent findings. Sports Med 32: 987-1004
23. Eliakim A et al. (2001) Fitness, training, and the growth hormone-insulin-like growth factor I axis in prepubertal girls. J Clin Endocrinol Metab 86: 2797-2802
24. Kraemer WJ et al. (1999) Effects of heavy-resistance training on hormonal response patterns in younger vs. older men. J Appl Physiol 87: 982-992
25. Kraemer WJ and Ratamess NA (2005) Hormonal responses and adaptations to resistance exercise and training. Sports Med 35: 339-361
26. Ho KY et al. (1988) Fasting enhances growth hormone secretion and amplifies the complex rhythms of growth hormone secretion in man. J Clin Invest 81: 968-975
27. Anderson SM et al. (2001) Short-term estradiol supplementation augments growth hormone (GH) secretory responsiveness to dose-varying GH-releasing peptide infusions in healthy postmenopausal women. J Clin Endocrinol Metab 86: 551-560
28. Veldhuis JD et al. (2004) Short-term testosterone supplementation relieves growth hormone autonegative feedback in men. J Clin Endocrinol Metab 89: 1285-1290
29. Armanini D et al. (2002) Growth hormone and insulin-like growth factor I in a Sydney Olympic gold medallist. Br J Sports Med 36: 148-149
30. Parker ML et al. (1962) Studies on human growth hormone. II. The physiological disposition and metabolic fate of human growth hormone in man. J Clin Invest 41: 262-268
31. Holl RW et al. (1993) Diurnal variation in the elimination rate of human growth hormone (GH): the half-life of serum GH is prolonged in the evening, and affected by the source of the hormone, as well as by body size and serum estradiol. J Clin Endocrinol Metab 77: 216-220
32. Veldhuis JD et al. (2002) Impact of experimental blockade of peripheral growth hormone (GH) receptors on the kinetics of endogenous and exogenous GH removal in healthy women and men. J Clin Endocrinol Metab 87: 5737-5745
33. Ho KY et al. (1989) The pharmacokinetics, safety and endocrine effects of authentic biosynthetic human growth hormone in normal subjects. Clin Endocrinol (Oxf) 30: 335-345
34. Flanagan DE et al. (1997) Urinary growth hormone following exercise to assess growth hormone production in adults. Clin Endocrinol (Oxf) 46: 425-429
35. Leger J et al. (1995) The wide variation in urinary excretion of human growth hormone in normal growing and growth hormone-deficient children limits its clinical usefulness. Horm Res 44: 57-63
36. Albini CH et al. (1988) Quantitation of urinary growth hormone in children with normal and abnormal growth. Pediatr Res 23: 89-92
37. Saugy M et al. (1996) Detection of human growth hormone doping in urine: out of competition tests are necessary. J Chromatogr B Biomed Appl 687: 201-211
38. Saugy M et al. (2006) Human growth hormone doping in sport. Br J Sports Med 40 (Suppl 1): i35-i39
39. World Anti-Doping Agency: World Anti-Doping Code-International Standard for Laboratories Version 4.0 August 2004 [http://www.wada-ama.org/rtecontent/ document/lab_aug_04.pdf] (accessed 18 July 2007)
40. Wallace JD et al. (1999) Responses of the growth hormone (GH) and insulin-like growth factor axis to exercise, GH administration, and GH withdrawal in trained adult males: a potential test for GH abuse in sport. J Clin Endocrinol Metab 84: 3591-3601
41. Le Roith D et al. (2001) The somatomedin hypothesis: 2001. Endocr Rev 22: 53-74
42. Wallace JD et al. (2000) Responses of markers of bone and collagen turnover to exercise, growth hormone (GH) administration, and GH withdrawal in trained adult males. J Clin Endocrinol Metab 85: 124-133
43. Burman P et al. (1997) Growth hormone (GH)-deficient men are more responsive to GH replacement therapy than women. J Clin Endocrinol Metab 82: 550-555
44. Dall R et al. (2000) The effect of four weeks of supraphysiological growth hormone administration on the insulin-like growth factor axis in women and men. GH-2000 Study Group. J Clin Endocrinol Metab 85: 4193-4200
45. Longobardi S et al. (2000) Growth hormone (GH) effects on bone and collagen turnover in healthy adults and its potential as a marker of GH abuse in sports: a double blind, placebo-controlled study. The GH-2000 Study Group. J Clin Endocrinol Metab 85: 1505-1512
46. Eliakim A et al. (1996) Physical fitness, endurance training, and the growth hormone-insulin-like growth factor I system in adolescent females. J Clin Endocrinol Metab 81: 3986-3992
47. Harrela M et al. (1996) Genetic and environmental components of interindividual variation in circulating levels of IGF-I, IGF-II, IGFBP-1, and IGFBP-3. J Clin Invest 98: 2612-2615
48. Juul A et al. (1995) Serum levels of insulin-like growth factor (IGF)-binding protein-3 (IGFBP-3) in healthy infants, children, and adolescents: the relation to IGF-I, IGF-II, IGFBP-1, IGFBP-2, age, sex, body mass index, and pubertal maturation. J Clin Endocrinol Metab 80: 2534-2542
49. Bang P et al. (1990) Exercise-induced changes in insulin-like growth factors and their low molecular weight binding protein in healthy subjects and patients with growth hormone deficiency. Eur J Clin Invest 20: 285-292
50. Hopkins NJ et al. (1994) Changes in circulating insulin-like growth factor-binding protein-1 (IGFBP-1) during prolonged exercise: effect of carbohydrate feeding. J Clin Endocrinol Metab 79: 1887-1890
51. Hornum M et al. (1997) Exercise-induced changes in circulating growth factors with cyclic variation in plasma estradiol in women. J Appl Physiol 82: 1946-1951
52. Schwarz AJ et al. (1996) Acute effect of brief low- and high-intensity exercise on circulating insulin-like growth factor (IGF) I, II, and IGF-binding protein-3 and its proteolysis in young healthy men. J Clin Endocrinol Metab 81: 3492-3497
53. Powrie JK et al. (2007) Detection of growth hormone abuse in sport. Growth Horm IGF Res 17: 220-226
54. Rigamonti AE et al. (2005) Growth hormone abuse: methods of detection. Trends Endocrinol Metab 16: 160-166
55. Healy ML et al. (2005) Toward the development of a test for growth hormone (GH) abuse: a study of extreme physiological ranges of GH-dependent markers in 813 elite athletes in the postcompetition setting. J Clin Endocrinol Metab 90: 641-649
56. Wright NM et al. (1995) Greater secretion of growth hormone in black than in white men: possible factor in greater bone mineral density - a clinical research center study. J Clin Endocrinol Metab 80: 2291-2297
57. Nelson AE et al. (2006) Influence of demographic factors and sport type on growth hormone-responsive markers in elite athletes. J Clin Endocrinol Metab 91: 4424-4432
58. Abellan R et al. (2006) Effect of physical fitness and endurance exercise on indirect biomarkers of recombinant growth hormone misuse: insulin-like growth factor I and procollagen type III peptide. Int J Sports Med 27: 976-983
59. Kurdy NM (2000) Serology of abnormal fracture healing: the role of PIIINP, PICP, and BsALP. J Orthop Trauma 14: 48-53
60. Baumann G (1999) Growth hormone heterogeneity in human pituitary and plasma. Horm Res 51 (Suppl 1): 2-6
61. Popii V and Baumann G (2004) Laboratory measurement of growth hormone. Clin Chim Acta 350: 1-16
62. Nakamoto JM et al. (1986) Suppression of the growth hormone (GH) response to clonidine and GH-releasing hormone by exogenous GH. J Clin Endocrinol Metab 62: 822-826
63. Leung KC et al. (2002) Physiological and pharmacological regulation of 20-kDa growth hormone. Am J Physiol Endocrinol Metab 283: E836-E843
64. Wu Z et al. (1999) Detection of doping with human growth hormone. Lancet 353: 895
65. Bidlingmaier M et al. (2000) Test method: GH. Baillieres Best Pract Res Clin Endocrinol Metab 14: 99-109
66. Wu Z et al. (2002) Development of human growth hormone (hGH) isoform specific antibodies and their use in a possible test to detect hGH-doping in sports. Abstract P3-527 presented at the 84th Meeting of the Endocrine Society: 2002 June 19-22, San Francisco, CA
67. Hashimoto Y et al. (2000) Exogenous 20K growth hormone (GH) suppresses endogenous 22K GH secretion in normal men. J Clin Endocrinol Metab 85: 601-606
68. Ishikawa M et al. (1999) Serum levels of 20-kilodalton human growth hormone (GH) are parallel those of 22-kilodalton human GH in normal and short children. J Clin Endocrinol Metab 84: 98-104
69. Wallace JD et al. (2001) Changes in non-22-kilodalton (kDa) isoforms of growth hormone (GH) after administration of 22-kDa recombinant human GH in trained adult males. J Clin Endocrinol Metab 86: 1731-1737
70. Wallace JD et al. (2001) The response of molecular isoforms of growth hormone to acute exercise in trained adult males. J Clin Endocrinol Metab 86: 200-206
71. Keller A et al. (2007) Pharmacokinetics and pharmacodynamics of GH: dependence on route and dosage of administration. Eur J Endocrinol 156: 647-653